NCT03091517 is a NA clinical trial of GlycoLeap in Type 2 Diabetes Mellitus, sponsored by Duke-NUS Graduate Medical School.

Who is sponsoring NCT03091517?

NCT03091517 is sponsored by Duke-NUS Graduate Medical School.

What drugs are being tested in NCT03091517?

Interventions in NCT03091517: GlycoLeap.

What condition does NCT03091517 study?

NCT03091517 studies Type 2 Diabetes Mellitus.

Is NCT03091517 still recruiting?

NCT03091517 is currently completed. Last updated 11 July 2018.

Last reviewed 2018-07-11 · How we verify

NCT03091517

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

A Single Arm Feasibility Study of GlycoLeap, an On-line Lifestyle Modification and Self-management Program for People With Type 2 Diabetes

Completed NA Last updated 11 July 2018

What this trial tests

NA trial testing GlycoLeap in Type 2 Diabetes Mellitus in 100 participants. Completed in 28 May 2018.

Timeline

22 June 2017

Primary endpoint
19 May 2018

28 May 2018

Quick facts

Lead sponsor	Duke-NUS Graduate Medical School
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	other
Enrollment	100
Start date	22 June 2017
Primary completion	19 May 2018
Estimated completion	28 May 2018
Sites	1 location across Singapore

Drugs / interventions tested

GlycoLeap

Conditions studied

Type 2 Diabetes Mellitus — all drugs for Type 2 Diabetes Mellitus →

Sponsor

Duke-NUS Graduate Medical School

Who can join

Adults 21 to 70, any sex, with Type 2 Diabetes Mellitus. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This single arm pilot study will explore the feasibility of GlycoLeap, a proprietary online lifestyle modification and self-management education program developed in Singapore for people with type 2 diabetes, as an add-on to primary care delivered through one of the SingHealth Polyclinics.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

A Mobile Lifestyle Management Program (GlycoLeap) for People With Type 2 Diabetes: Single-Arm Feasibility Study.
Koot D, Goh PSC, Lim RSM, Tian Y, et al · · 2019 · cited 38× · PMID 31127720 · DOI 10.2196/12965

Verify or expand the search:

Other recruiting trials for Type 2 Diabetes Mellitus

Currently open trials in the same condition.

NCT07351058 — A Clinical Study to Evaluate the Effects of RO7795068 in Participants With Obesity or Overweight and Type 2 Diabetes · Phase 3 · recruiting
NCT07373938 — Carotid Wall Texture as a Cardiovascular Risk Biomarker in Type 2 Diabetes Mellitus · recruiting
NCT07433062 — A Study to Evaluate the Effect of AZD6793 on the Pharmacokinetics and Pharmacodynamics of Metformin in Participants With · Phase 1 · recruiting
NCT07276776 — An Evaluation of the Omnipod® M System in Adults With Type 2 Diabetes · NA · active not recruiting
NCT07232537 — An Observational Study Called FINE-REAL Korea to Learn More About the Use of the Drug Finerenone in People With Chronic · recruiting

Other Duke-NUS Graduate Medical School trials

Trials by the same sponsor.

NCT07309367 — Web-based Advance Care Planning Intervention for Patients With Kidney Failure on Dialysis: Pilot Testing of 'My Voice' · NA · recruiting
NCT06817876 — Connecting Caregivers With Community Services: The Care Buddy Platform · NA · recruiting
NCT06440421 — Understanding Food Choices in Bahrain Using Bahrain e-Mart · NA · completed
NCT06102954 — A Multi-domain and Multi-component Falls Intervention Program for Community- Dwelling Older Adults: SAFE-TECH · NA · recruiting
NCT06155981 — Coca-Cola Zero (®) Consumption on Night-call Inpatient Course and Mortality · NA · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03091517 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Duke-NUS Graduate Medical School
Last refreshed: 11 July 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03091517.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing